Nucleic acid extraction and purification is an important aspect of genetic testing since it supplies the starting material for any genetic study, and significant advances have been made in establishing techniques to offer high-quality nucleic acid for future genetic research.
The emergence of modern technology with automated systems and ways to acquire high-quality nucleic acid has facilitated the extraction, isolation, purification, and other processes in sample preparation. Increased demand for high-quality reagent kits and related items has resulted from advancements in the nucleic acid sample preparation procedure. Various researchers and manufacturers have developed automated resources to generate high-quality samples in quick turnaround periods. High throughput and sophisticated sample preparation technology, as well as collaborations developed with key research institutions throughout the world to improve sampling methodology, are expected to fuel market expansion during the forecast period 2022-2032.
Nucleic Acid Sample Preparation Market is projected to reach $11,200.5 million by 2032 from $4,213.0 million in 2022, growing at a CAGR of 10.27% during the forecast period 2022-2032. The growth in the global nucleic acid sample preparation market is expected to be driven by the increased use of nucleic acid molecules in several therapeutic areas. In addition, the increased demand for downstream applications such as next-generation sequencing (NGS) and others and the advancement in nucleic acid extraction/isolation techniques have driven the growth of the nucleic acid sample preparation market.
Market Lifecycle Stage
The global nucleic acid sample preparation market is in a progressing phase. To meet the growing need for timely diagnostic information and targeted patient treatment, several molecular procedures, including automated nucleic acid sample preparation workstations, have been developed. In addition, sample preparation is essential in precision medicine because it assures the safe and successful use of tailored therapies. The market offers a range of universal products with varied maximum throughputs, innovations, time durations, and other qualities, and companies are searching for innovative methods to distinguish themselves. Additionally, manufacturers began to produce application-specific nucleic acid purification devices and liquid handlers in recent years.
Market Segmentation:
Segmentation 1: by Product
• Systems
• Consumables
• Accessories and Components
Based on product, the consumables segment in the global nucleic acid sample preparation market dominated in FY2021. This was due to the increase in the adoption of kits and reagents in this market.
Segmentation 2: by Workflow
• Sample Extraction/Isolation
• Sample Quantification
• Quality Control
• Fragmentation
• Target Enrichment
• Library Quantification
• Pooling
Based on the workflow, the global nucleic acid sample preparation market was dominated by sample extraction/isolation in FY2021. The high share associated with sample extraction/isolation in the nucleic acid sample preparation ecosystem is majorly attributed to the growing prevalence of oncology medical conditions and rising emphasis on research procedures.
Segmentation 3: by Technology
• Spin-Column Based Technology
• Magnetic-Bead Based Technology
• Other Technologies
Based on technology, the spin column-based technology segment accounted for the largest share of the global nucleic acid sample preparation in FY2021. The large share of this segment can be attributed to the increasing adoption of global nucleic acid sample preparation products, the growing demand to perform rapid and efficient extraction, and the rising need to reduce the sample-to-sample variation arising from the manual process.
Segmentation 4: by Therapeutic Area
• Oncology
• Human Genetics/Population Genetics
• Infectious Disease
• Others
Based on the therapeutic area, the global nucleic acid sample preparation market was dominated by the oncology segment in FY2021, owing to an increase in cancer cases. Sample preparation can make a big difference in the field of oncology because it offers a number of benefits in terms of sensitivity, specificity, and outcomes.
Key Companies Profiled
• Agilent Technologies, Inc.
• Aurora Biomed Inc.
• BGI Group (MGI Tech Co., Ltd.)
• BIONEER CORPORATION.
• Blue-Ray Biotech Corp.
• Danaher. (Beckman Coulter, Inc.)
• Endress+Hauser Group Services AG (Analytik Jena GmbH)
• Eppendorf SE
• F. Hoffmann-La Roche Ltd
• Illumina, Inc.
• Merck KGaA
• Norgen Biotek Corp.
• OPENTRONS
• PerkinElmer Inc.
• Promega Corporation
• QIAGEN
• Sansure Biotech Inc.
• Tecan Trading AG
• Thermo Fisher Scientific Inc.
Get Free Sample Report - https://bisresearch.com/requestsample?id=1438&type=download
Additionally, BIS Research also offers a dedicated and unique platform to find and access deeptech insights and updates on emerging technologies across industry verticals. Insight Monk, an AI powered deeptech search engine, is a subscription based platform that offers a library of latest market insights and updates based on emerging tech. Learn more about InsightMonk here. https://www.insightmonk.com